We are live on ! Find out more
PGNX

Progenics Pharmaceuticals Inc
PGNX

Delisted

PGNX was delisted on the 19th of June, 2020.

Back to rankings

Fund managers haven’t disclosed any holdings of PGNX yet.

PGNX Hedge Fund Activity: Q3 2020 in Review

0 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Progenics Pharmaceuticals Inc (PGNX) for Q3 2020, worth a combined $0 — down 100% from $177K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PGNX and 0 opened new positions — a net loss of 3 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Everence Capital Management, exiting entirely with an estimated $123K sold.

  • 0 institutional investors held Progenics Pharmaceuticals Inc (PGNX) as of Q3 2020, down from 3 in Q2 2020.
  • Funds reported $0 of Progenics Pharmaceuticals Inc stock for Q3 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Progenics Pharmaceuticals Inc positions in Q3 2020 and 3 closed out, a net change of -3 holders.
  • The largest Progenics Pharmaceuticals Inc seller in Q3 2020 was Everence Capital Management, an estimated $123K sold.

Based on aggregated 13F filings for Q3 2020.